Human gut microbiome and risk for colorectal cancer

Journal of the National Cancer Institute

Volumn 105, Issue 24, 2013, Pages 1907-1911

  Ahn, Jiyoung ^a,b   Sinha, Rashmi ^c   Pei, Zhiheng ^a,b,d   Dominianni, Christine ^a,b   Wu, Jing ^a,b   Shi, Jianxin ^c   Goedert, James J ^c   Hayes, Richard B ^a,b   Yang, Liying ^a  

^a NEW YORK UNIVERSITY   (United States)

^b University School of Medicine   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; RNA 16S;

ARTICLE; CANCER RISK; CLOSTRIDIA; COLORECTAL CANCER; DISEASE ASSOCIATION; DISEASE CARRIER; FECES MICROFLORA; FUSOBACTERIUM; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HYPOTHESIS; IMMUNOASSAY ANALYZER; INTESTINE FLORA; MICROBIAL GENOME; MICROBIOME; POLYMERASE CHAIN REACTION; PORPHYROMONAS; PRIORITY JOURNAL; TAXONOMY;

EID: 84891473723     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djt300     Document Type: Article

References (29)

1. O'Keefe SJ. Nutrition and colonic health: the critical role of the microbiota. Curr Opin Gastroenterol. 2008;24(1):51-58.
2. Koropatkin NM, Cameron EA, Martens EC. How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol. 2012;10(5):323-335.
3. Yang L, Pei Z. Bacteria, inflammation, and colon cancer. World J Gastroenterol. 2006; 12(42):6741-6746.
4. Kinross JM, von Roon AC, Holmes E, Darzi A, Nicholson JK. The human gut microbiome: implications for future health care. Curr Gastroenterol Rep. 2008;10(4):396-403.
5. Horie H, Kanazawa K, Okada M, Narushima S, Itoh K, Terada A. Effects of intestinal bacteria on the development of colonic neoplasm: an experimental study. Eur J Cancer Prev. 1999;8(3):237-245.
6. Moore WE, Moore LH. Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol. 1995;61(9):3202-3207.
7. Kostic AD, Gevers D, Pedamallu CS, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012;22(2):292-298.
8. Castellarin M, Warren RL, Freeman JD, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22(2):299-306.
9. Schiffman MH, Van Tassell RL, Robinson A, et al. Case-control study of colorectal cancer and fecapentaene excretion. Cancer Res. 1989;49(5):1322-1326.
10. Schiffman MH, Andrews AW, Van Tassell RL, et al. Case-control study of colorectal cancer and fecal mutagenicity. Cancer Res. 1989;49(12):3420-3424.
11. Ahn J, Yang Y, Paster BJ, et al. Oral microbiome profiles: 16S rRNA pyrosequencing and microarray assay comparison. PLoS One. 2011;6(7):e22788- 22795.
12. Nossa CW, Oberdor WE, Yang L, et al. In silico design of 16S rRNA gene primers for analysis of human foregut microbiome using next generation sequencing technology. World J Gastroenterol. 2010;16(33): 4135-4144.
13. Haas BJ, Gevers D, Earl AM, et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 2011;21(3):494-504.
14. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335-336.
15. Sanapareddy N, Legge RM, Jovov B, et al. Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans. Isme J. 2012;6(10):1858-1868.
16. Knoch B, Nones K, Barnett MP, McNabb WC, Roy NC. Diversity of caecal bacteria is altered in interleukin-10 gene-deficient mice before and after colitis onset and when fed polyunsaturated fatty acids. Microbiology. 2010;156(Pt 11):3306-3316.
17. Rinttila T, Kassinen A, Malinen E, Krogius L, Palva A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol. 2004;97(6):1166-1177.
18. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B. 1995;57(1):289-300.
19. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008;27(2):104-119.
20. Ohkusa T, Okayasu I, Ogihara T, Morita K, Ogawa M, Sato N. Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut. Jan 2003;52(1):79-83.
21. Signat B, Roques C, Poulet P, Duffaut D. Fusobacterium nucleatum in periodontal health and disease. Curr Issues Mol Biol. 2011;13(2):25-36.
22. Ahn J, Segars S, Hayes RB. Periodontal Disease, Porphyromonas gingivalis (P. gingivalis) serum antibody levels and orodigestive cancer mortality. Carcinogenesis. 2012;33(5):1055-1058.
23. Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One. 2012;7(6):e39743.
24. Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006;55(2):205-211.
25. Altonsy MO, Andrews SC, Tuohy KM. Differential induction of apoptosis in human colonic carcinoma cells (Caco-2) by Atopobium, and commensal, probiotic and enteropathogenic bacteria: mediation by the mitochondrial pathway. Int J Food Microbiol. 2010;137(2-3):190-203.
26. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366(9499): 1809-1820.
27. Frantzen MA, Silk JB, Ferguson JW, Wayne RK, Kohn MH. Empirical evaluation of preservation methods for faecal DNA. Mol Ecol. 1998;7(10):1423-1428.
28. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457(7228):480-484.
29. Human Microbiome Project: Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207-214.